Kane Biotech Schedules First Quarter 2018 Earnings Conference Call and Business Update
Conference call to take place Friday, May 18, 2018 at 8:30am E.T.
WINNIPEG, Manitoba – (Globe Newswire – May 10, 2018) – Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will host a conference call on Friday, May 18, 2018 at 8:30am E.T. to discuss its financial results for the first quarter 2018, in conjunction with the filing of its Quarterly Financial Statements for the first quarter ended March 31, 2018.
Mark Ahrens-Townsend, President and Chief Executive Officer, and Ray Dupuis, Chief Financial Officer of Kane, will host the call and provide an update on recent developments and clinical progress. Management will be answering questions live immediately following the earnings announcement part of the call.
To participate in the call, please dial +1 877-268-9044 (toll-free) in the U.S. and Canada. The conference ID number is 9749257.
Event: Kane Biotech Q1 2018 Earnings & Business Update Conference Call
Date: Friday, May 18, 2018
Time: 8:30am E.T.
U.S. & Canada Dial-in: 877-268-9044 (toll free in Canada and the U.S.)
Conference ID: 9749257
Webcast Link: https://edge.media-server.com/m6/p/qwnb3dc7
A live audio webcast of the conference call will also be available on the investor relations page of Kane’s corporate website at www.kanebiotech.com. In addition, the recorded conference call can be replayed and will be available for 90 days following the call on Kane’s website.